Replies to post #86140 on Anavex Life Sciences Corp (AVXL)

[bas2020]

Well put. When common sense, logic and probability are applied, it's simply irrefutable.

[Cbdpotential]

Eloquent

[LakeshoreLeo1953]

No parsing your conclusions.

My major concern with N is not the 25. I was content with the
toxicity/safety end points of P2. That the secondary end point
promises possibly tremendous efficacy is highly interesting.

But, what of the 7? Fully 21% of the initial group dropped.
The Overall demographics were younger and more moderate stage
than mean statistics from previous trials.

I am anxious for all the hyperbole to be tested in an FDA approved and
Market satisfying test group population P3. That will take money and TRUE
interest from a marketing/production savy BP. I can wait, but I won't
bet the house.